Consistently, the expression of the BMP antagonist noggin seems to be restricted to those tumor cells that preferentially induce osteolytic bone metastasis, while the forced expression of noggin in osteosclerotic PCa cells inhibited their ability to induce osteoblast metastases [104]. This evidence concerns the gene NOG and neoplasm.